A predictive model utilizing serum metabolic profiles was able to distinguish ovarian cancer from control samples with 93% accuracy, according to a new study. Machine learning–based classification ...
Observational study examining the feasibility of generating real-world evidence (RWE) for new drug applications from the clinical trials database (DB; RELIASE study). This is an ASCO Meeting Abstract ...
Making a personalized T cell therapy for cancer patients currently takes at least six months. Scientists have shown that the laborious first step of identifying tumor-reactive T cell receptors for ...
Producing the highest accuracy, the 9-gene set produced became the basis of the final classifier. When applied to multiple ...
The blood-based test by Astrin Biosciences shows high sensitivity and specificity across cancer stages and subtypes, ...
In a recent study published in Molecular Psychiatry, researchers performed structural-type magnetic resonance imaging (sMRI) to develop a machine learning classifier and distinguish neuroanatomical ...
Making a personalised T cell therapy for cancer patients currently takes at least six months; scientists at the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results